Related Experiment Video
Updated: Jul 20, 2026

On-Chip Endothelial Inflammatory Phenotyping
Published on: July 21, 2012
Endothelial monocyte-activating polypeptide-II and its functions in (patho)physiological processes
Remco van Horssen1, Alexander M M Eggermont, Timo L M ten Hagen
1Laboratory of Experimental Surgical Oncology, Department of Surgical Oncology, Erasmus University MC - Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. r.vanhorssen@ncmls.ru.nl
Abstract:
Endothelial monocyte-activating polypeptide-II (EMAP-II) is a pro-inflammatory cytokine with anti-angiogenic properties. Its precursor, proEMAP, is identical to the p43 auxiliary component of the tRNA multisynthetase complex and therefore involved in protein translation. Although most of the activities have been ascribed to the active form EMAP-II, also p43 has reported cytokine properties. ProEMAP/p43 and EMAP-II act on many levels and on many cell types including endothelial cells, immune cells and fibroblasts. In this review we summarize all available data on isolation, expression and functions of EMAP-II both in physiological processes as well as in pathological settings, like cancer. We also discuss the different reported mechanisms for processing of proEMAP/p43 into EMAP-II. Finally, we speculate on the possible applications of this cytokine for (cancer) therapy.
Insights
Endothelial monocyte-activating polypeptide-II (EMAP-II) is a cytokine involved in inflammation and angiogenesis. This review covers EMAP-II
Area of Science:
- Molecular Biology
- Immunology
- Cell Biology
Background:
- Endothelial monocyte-activating polypeptide-II (EMAP-II) is a pro-inflammatory cytokine.
- Its precursor, proEMAP/p43, is linked to protein translation via the tRNA multisynthetase complex.
- Both proEMAP/p43 and EMAP-II exhibit cytokine properties and affect various cell types.
Purpose of the Study:
- To review existing data on the isolation, expression, and functions of EMAP-II.
- To explore EMAP-II's roles in physiological and pathological conditions, particularly cancer.
- To discuss proEMAP/p43 processing into EMAP-II and potential therapeutic applications.
Main Methods:
- Literature review of published data.
- Analysis of studies on EMAP-II isolation and expression.
- Examination of research on EMAP-II functions in various cell types and disease models.
Main Results:
- EMAP-II possesses pro-inflammatory and anti-angiogenic activities.
- ProEMAP/p43, the precursor, also has cytokine properties and is involved in translation.
- EMAP-II and its precursor impact endothelial cells, immune cells, and fibroblasts.
Conclusions:
- EMAP-II is a multifunctional cytokine with significant roles in both normal physiology and disease, especially cancer.
- Understanding the processing of proEMAP/p43 to EMAP-II is crucial.
- EMAP-II holds potential for novel cancer therapies.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Differentiation of Common Myeloid Progenitor Cells
Acute Inflammation II: Cellular Phase
Coronary Artery Disease II: Pathophysiology
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...

